Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-05

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved the original ANDA for dexmethylphenidate hydrochloride from Amneal Pharmaceuticals of New York LLC, a generic formulation for ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)